IMR Press / JIN / Special Issues / cognitive_enhancement

Cognitive Enhancement

Submission deadline: 30 September 2022
Special Issue Editor
Newton Howard, PhD
Oxford Computational Neuroscience Lab (OxCNL), University of Oxford, Oxford, UK
Interests: synthetic intelligence; exchange of information; memory; trauma; mind machine; functional brain; neuron interfacing abilities
Special Issue Information

Dear Colleagues,

Much of modern neurological medicine has focused on treating an already diseased brain, essentially to mitigate any shortcomings that prevent normal thinking, behavior, or action. In contrast, cognitive enhancement is focused on improving a healthy and normal brain. Cognitive enhancement includes augmentation, diminishment, and optimization. Brain augmentation increases the brain’s capability for normal processes beyond what is necessary for maintaining proper health. Diminishment decreases the brain capacity for certain processes that negatively impact task performance. Optimization balances overall brain activity, ensuring it remains flexible and adaptive to a changing environment. The two main methods for cognitive enhancement are through the use of pharmaceutical agents and neural stimulation. These methods alter the flow of neurotransmitters, thereby stimulating and depressing certain neural pathways to achieve their intended effect. The potential for future technologies is vast, though ethical concerns should also be considered as humans are made more capable.

This special issue will discuss many topics in cognitive enhancement including augmentation, diminishment, and optimization. We will cover various methods for cognitive enhancement including pharmaceuticals, stimulation, and brain-computer interfaces. We will also cover the physiology and mechanisms behind cognitive enhancement, the history of cognitive enhancement, current state of the art, and future directions in this field. 

Prof. Dr. Newton Howard

Guest Editor

Keywords
transcranial direct current stimulation (tDCS)
transcranial magnetic stimulation (TMS)
neurodegeneration
Alzheimer’s disease
Parkinson’s disease
mood regulation
methylphenidate
dextroamphetamine
acetylcholinesterase inhibitors
modafnil
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1900 USD. Submitted manuscripts should be well formatted in good English.

Back to top